A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment

Clinical trial NCT05537142 · COMPLETED

Trial details

NCT number: NCT05537142
Sponsor: BioVersys AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2022-09-02
Primary completion: 2024-07-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.